Literature DB >> 33164554

Biobanking in the COVID-19 Era and Beyond: Part 1. How Early Experiences Can Translate into Actionable Wisdom.

Clare M Allocca1, Marianna J Bledsoe2, Monique Albert3, Sergey V Anisimov4, Elena Bravo5, Marta G Castelhano6, Yehudit Cohen7, Mieke De Wilde8, Koh Furuta9,10, Zisis Kozlakidis10, Dunja Martin11, Anabela Martins12, Shannon McCall13, Helen Morrin14, Rebecca S Pugh15, Brent Schacter16, Daniel Simeon-Dubach17, Emma Snapes18.   

Abstract

The era of COVID-19 has brought about a number of novel challenges for the global biobanking community. To better position the biobanking community to cope with current and future challenges, the International Society for Biological and Environmental Repositories (ISBER) COVID-19 Response Task Force was convened to identify needs and gaps in biobanking tools (existing resources that support good practice), for example, standards, best practices, business, etc. and to make recommendations to benefit the community. Toward these goals, the Task Force assembled a set of questions to explore individual biobanks' experiences, with emphasis on identification of key challenges and approaches, including tools employed. A survey was designed with the use of these questions and administered by ISBER. This article presents a summary of the aggregated data obtained from the survey responses, illustrating some of the major issues encountered and identifying which tools the survey respondents found most useful. In particular, this article focuses on the challenges identified during the early months of the COVID-19 era. Recommendations are provided to support biobank emergency preparedness for the future, address lessons learned, and propose solutions to bridge identified gaps. The analysis and the complete survey dataset will also inform the larger Task Force goal to develop specific tool recommendations.

Entities:  

Keywords:  COVID-19; best practices; biobank; standards; survey; tools

Mesh:

Year:  2020        PMID: 33164554     DOI: 10.1089/bio.2020.0082

Source DB:  PubMed          Journal:  Biopreserv Biobank        ISSN: 1947-5543            Impact factor:   2.300


  5 in total

1.  Biobanking in the COVID-19 Era and Beyond: Part 2. A Set of Tool Implementation Case Studies.

Authors:  Clare M Allocca; Emma Snapes; Monique Albert; Marianna J Bledsoe; Marta G Castelhano; Mieke De Wilde; Koh Furuta; Zisis Kozlakidis; Dunja Martin; Anabela Martins; Shannon J McCall; Brent Schacter
Journal:  Biopreserv Biobank       Date:  2020-11-18       Impact factor: 2.300

Review 2.  Opportunities and Risks for Research Biobanks in the COVID-19 Era and Beyond.

Authors:  Daniel Simeon-Dubach; Marianne K Henderson
Journal:  Biopreserv Biobank       Date:  2020-10-08       Impact factor: 2.300

3.  Challenges to biobanking in LMICs during COVID-19: time to reconceptualise research ethics guidance for pandemics and public health emergencies?

Authors:  Shenuka Singh; Rosemary Jean Cadigan; Keymanthri Moodley
Journal:  J Med Ethics       Date:  2021-05-12       Impact factor: 5.926

Review 4.  The Availability of Human Biospecimens to Support Biomarker Research.

Authors:  Tamsin E Tarling; Jennifer A Byrne; Peter H Watson
Journal:  Biomark Insights       Date:  2022-04-19

5.  Building Research Support Capacity across Human Health Biobanks during the COVID-19 Pandemic.

Authors:  Jennifer A Byrne; Jane E Carpenter; Candace Carter; Kathleen Phillips; Stephen Braye; Peter H Watson; Amanda Rush
Journal:  Biomark Insights       Date:  2021-06-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.